Definitive Contract W58P0521C0002

Award Date 7/30/21
Potential Completion Date 2/29/24
Potential Value $6.9B
Funding Federal Agency
Bureau for Global Health
Contracting Federal Agency
Office of the Assistant Administrator
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10017, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed

This is a definitive contract awarded to Pfizer Inc. by the Bureau for Global Health, a civilian agency, to provide COVID-19 vaccines for international donation. The contract has a ceiling value of $6,859,517,906.00 and a completion date of February 29, 2024. The contract is a firm fixed-price arrangement without any set-aside designation. Pfizer is the prime contractor, and there are no major subcontractors mentioned. This contract likely supports the agency's efforts to distribute COVID-19 vaccines globally as part of broader public health initiatives. Pfizer is a large pharmaceutical company that has previously been awarded significant indefinite delivery vehicle (IDV) contracts with the Department of Veterans Affairs and the Centers for Disease Control and Prevention for a range of pharmaceutical products and adult vaccines.

Generated 9/20/24, 9:33 AM